The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects

British Journal of Pharmacology
Dominique KavvadiasPeter Schreier

Abstract

The functional characterization of hispidulin (4',5,7-trihydroxy-6-methoxyflavone), a potent benzodiazepine (BZD) receptor ligand, was initiated to determine its potential as a modulator of central nervous system activity. After chemical synthesis, hispidulin was investigated at recombinant GABA(A)/BZD receptors expressed by Xenopus laevis oocytes. Concentrations of 50 nm and higher stimulated the GABA-induced chloride currents at tested receptor subtypes (alpha(1-3,5,6)beta(2)gamma(2)S) indicating positive allosteric properties. Maximal stimulation at alpha(1)beta(2)gamma(2)S was observed with 10 microm hispidulin. In contrast to diazepam, hispidulin modulated the alpha(6)beta(2)gamma(2)S-GABA(A) receptor subtype. When fed to seizure-prone Mongolian gerbils (Meriones unguiculatus) in a model of epilepsy, hispidulin (10 mg kg(-1) body weight (BW) per day) and diazepam (2 mg kg(-1) BW per day) markedly reduced the number of animals suffering from seizures after 7 days of treatment (30 and 25% of animals in the respective treatment groups, vs 80% in the vehicle group). Permeability across the blood-brain barrier for the chemically synthesized, (14)C-labelled hispidulin was confirmed by a rat in situ perfusion model. With an uptak...Continue Reading

References

Jan 1, 1992·Environmental and Molecular Mutagenesis·M ChulasiriP Moongkarndi
Feb 1, 1995·Italian Journal of Neurological Sciences·R BertorelliE Ongini
Jan 14, 1998·Trends in Pharmacological Sciences·E Sigel, A Buhr
Nov 13, 1998·Journal of Pharmaceutical Sciences·R D EgletonT P Davis
Sep 11, 1999·FEBS Letters·J P SpencerC Rice-Evans
Feb 7, 2001·Biochemical Pharmacology·R AvalloneM Baraldi
Aug 25, 2001·Epilepsia·D M Treiman
Aug 13, 2002·Current Topics in Medicinal Chemistry·W Sieghart, G Sperk
Feb 15, 2003·European Journal of Pharmacology·Juan D GoutmanDaniel J Calvo
Mar 19, 2003·Journal of Neurochemistry·Kuresh A YoudimCatherine Rice-Evans
Aug 5, 2003·Pharmacology, Biochemistry, and Behavior·Mariel MarderAlejandro C Paladini
Feb 26, 2004·Free Radical Biology & Medicine·Kuresh A YoudimN Joan Abbott
May 1, 1998·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·J H MedinaA C Paladini

❮ Previous
Next ❯

Citations

May 12, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·B ZarroukiC O Soulage
Sep 9, 2010·Chemical & Pharmaceutical Bulletin·Fatma Abdel-Fattah RagabAhmed Mahmoud El Kerdawy
Oct 26, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Chao Yuan YuYi-Lin Sophia Chen
Oct 1, 2013·Neurochemical Research·Belinda J HallJane R Hanrahan
Mar 25, 2014·Cell Biochemistry and Biophysics·Xinhuan NiuMengyuan Zhang
May 16, 2008·Journal of Pharmaceutical Sciences·Kiril LanevskijAlanas Petrauskas
Sep 28, 2013·The Journal of Nutritional Biochemistry·Eleni OberbauerLudwig Aigner
Jul 5, 2012·Toxicology and Applied Pharmacology·Tzu-Yu LinSu-Jane Wang
May 24, 2012·Phytotherapy Research : PTR·Youngpyo NamKyoungho Suk
Jul 29, 2010·The Journal of Pharmacy and Pharmacology·Eduardo L G MoreiraRosa Maria Ribeiro-do-Valle
Jan 20, 2011·British Journal of Pharmacology·Jane R HanrahanGraham A R Johnston
Dec 17, 2010·Biopharmaceutics & Drug Disposition·Ying WangKui Wang
Mar 28, 2013·Phytotherapy Research : PTR·Arjan ScheepensMargot Skinner
Jul 25, 2006·Brain Research·Michel VignesMax Récasens
May 16, 2006·European Journal of Pharmacology·Sebastián P FernándezMariel Marder
Jul 21, 2015·Neurochemistry International·Graham A R Johnston
Mar 10, 2015·European Journal of Pharmacology·Tzu Yu LinShu Kuei Huang
Aug 7, 2013·European Journal of Pharmacology·Cecilia I CaleroDaniel J Calvo
Mar 1, 2011·Journal of Ethnopharmacology·Neeraj ChoudharyAjudhia N Kalia
Jun 12, 2013·Epilepsy & Behavior : E&B·Marjan Nassiri-AslParisa Bazahang
Jun 14, 2016·Scientific Reports·Mei-Lin ShenDong Chuan Wu
Oct 25, 2016·Lipids·Xinchi Wu, Juan Xu
Nov 14, 2016·Cellular and Molecular Life Sciences : CMLS·Sunita A RameshBo Xu
Dec 27, 2016·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Graham A R Johnston
Nov 9, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Liang-Chieh ChenWei-Jan Huang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.